Emerging immunotherapy targets in lung cancer

by Hao-Hua Zhu, Yu Feng, Xing-Sheng Hu, Pei-Fang Wei
Published 2020-10-01

Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma

by Jia-Ni Wang, Quan-Hui Qiao, Xing-Sheng Hu, Yu-Tao Liu, Zhi-Jie Wang, Jian-Chun Duan, Yu Feng, Hao-Hua Zhu, Li-Shao Guo
Published 2021-09-01

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis

by Hao‐Hua Zhu, Yu‐Tao Liu, Yu Feng, Li‐Na Zhang, Tong‐Mei Zhang, Gui‐Lan Dong, Pu‐Yuan Xing, Hong‐Yu Wang, Yuan‐Kai Shi, Xing‐Sheng Hu
Published 2021-10-01

Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China

by Hong-Shuai Li, Guang-Jian Yang, Yi Cai, Jun-Ling Li, Hai-Yan Xu, Tao Zhang, Li-Qiang Zhou, Yu-Ying Wang, Jin-Liang Wang, Xing-Sheng Hu, Xiang Yan, Yan Wang
Published 2022-06-01

Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon <i>EGFR</i> Mutations: A Co...

by Hong-Shuai Li, Shou-Zheng Wang, Hai-Yan Xu, Xiang Yan, Jin-Yao Zhang, Si-Yu Lei, Teng Li, Xue-Zhi Hao, Tao Zhang, Guang-Jian Yang, Li-Qiang Zhou, Peng Liu, Yu-Ying Wang, Xing-Sheng Hu, Pu-Yuan Xing, Yan Wang
Published 2022-10-01

Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients

by Li‐Ling Huang, Xing‐Sheng Hu, Yan Wang, Jun‐Ling Li, Hong‐Yu Wang, Peng Liu, Jian‐Ping Xu, Xiao‐Hui He, Xue‐Zhi Hao, Pei‐Di Jiang, Yu‐Tao Liu, Jian Luo, Sheng‐Yu Zhou, Jin‐Wan Wang, Jian‐Liang Yang, Yan Qin, Peng Yuan, Lin Lin, Yuan‐Kai Shi
Published 2021-07-01